TabarL, VitakB, ChenTHH, Swedish Two-County trial: Impact of mammographic screening on breast cancer mortality during 3 decades. Radiology2011;260:658–63
2.
Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev2006;15:45–51
3.
GabeR, TryggvadottirL, SigfussonBF, A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol2007;48:948–55
4.
OlsenAH, NjorSH, VejborgI, Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ2005;330:220; doi: 10.1136/bmj.38313.639236.82
5.
AnttilaA, SarkealaT, HakulinenT, Impacts of the Finnish service screening programme on breast cancer rates. BMC Public Health2008;8:38; doi: 10.1186/1471-2458-8-38
6.
PaapE, HollandR, den HeetenGJ, A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study. Cancer Causes Control2010;21:1569–73
7.
HellquistBN, DuffySW, AbdsalehS, Effectiveness of population-based service screening with mammography for women ages 40 to 49 years. Cancer2011;117:714–22
8.
U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task recommendation statement. Ann Intern Med2009;151:716–26
9.
KopansDB. The 2009 US Preventive Services Task Force (USPSTF) guidelines are not supported by science: The scientific support for mammography screening. Radiol Clin N Am2010:48:843–57
10.
JørgensenKJ, KeenJD, GøtzschePC. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality?Radiology2011;260:621–7
11.
ZahlPH, StrandBH, MæhlenJ. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ2004;328:921–4
12.
KopansDB, SmithRA, DuffySW. Mammographic screening and “overdiagnosis”. Radiology2011;260:616–20
13.
KalagerM, ZelenM, LangmarkF, Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med2010;363:1203–10
14.
AutierP, BoniolM, GavinA, Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ2011; doi: 10.1136/bmj.d4411
15.
LyngeE, BraatenT, NjorSH, Mammography activity in Norway 1983 to 2008. Acta Oncol2011;50:1062–7
16.
KerlikowskeK, MigliorettiDL, BuistDSM, Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst2007;99:1335–9
17.
HofvindS, SakshaugS, UrsinG, Breast cancer incidence trends in Norway – explained by hormone therapy or mammographic screening?Int J Cancer2011; doi: 10.1002/ijc.26280
18.
SkaaneP. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: Updated review. Acta Radiol2009;50:3–14
19.
WarrenR, EletiA. Overdiagnosis and overtreatment of breast cancer: Is overdiagnosis an issue for radiologists?Breast Cancer Research2006;8:205; doi: 10.1186/bcr1396
20.
HallFM. Identification, biopsy, and treatment of poorly understood premalignant, in situ, and indolent low-grade cancers: Are we becoming victims of our own success?Radiology2010;254:655–9
21.
KopansDB. Bias in the medical journals: A commentary (Informed decision making: Age of 50 is arbitrary and has no demonstrated influence on breast cancer screening in women). Am J Roentgenol2005;185:178–82
22.
MokbelK. The Norwegian study suggests that the BMJ is biased against breast cancer screening. BMJ2011; doi:10.1136/bmj.d4692
